glp 1 in type 1 diabetes GLP-1 for Weight Loss and GLP-1 Receptor Agonists: A Game-Changer

Description

Side effects and therapeutic response are not the same measurement

[DOI] [PubMed] [Google Scholar] [123].Buse JB, Nauck M, Forst T, Sheu WH, Shenouda SK, Heilmann CR, Hoogwerf BJ, Gao A, Boardman MK, Fineman M, Porter L, Schernthaner G, Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study, Lancet, 381 (2013) 117124

Studies show that stopping GLP-1 therapy can lead to weight regain, which is why we focus on sustainable lifestyle changes alongside medication

Due to the fact that there was no proof of the benefit of the statins in NAFLD/NASH based on liver biopsy, a pilot study was conducted on 20 subjects to evaluate the effect of 10 mg per day of rosuvastatin in biopsy-proven NASH